Phase II trial of fortnightly irinotecan (CPT-11) in the treatment of colorectal cancer patients resistant to previous fluoropyrimidine-based chemotherapy
Carlos García-Girón, Andrés García Palomo, Carmen Alonso López, Ángel León Carbonero, Miguel Méndez Urena, Encarna Adróver Cebrián, Ramón Barceló Galíndez, Mónica Arroyo Yustos, José Álvarez GallegoVolume:
7
Language:
english
Pages:
6
DOI:
10.1007/bf02710170
Date:
July, 2005
File:
PDF, 133 KB
english, 2005